MyFinsight
Home
About
Contact
namsw: the income statement
Download
Download image
Total comprehensive
loss for the period,...
-$71,692K
Unrealized gain/(loss) on
available-for-sale securities, net...
$313K
Loss for the period
-$72,005K
Loss before tax
-$72,005K
Foreign exchange
gains/(losses)
$218K
Interest income
$6,713K
Loss on disposal of
property, plant and...
-$1K
Fair value change -
warrants
$23,792K
Operating loss
-$55,143K
Revenue
$348K
Total operating
expenses
$55,491K
Selling, general and
administrative expenses
$24,520K
Research and development
expenses
$30,971K
Back
Back
Income Statement
source: myfinsight.com
NewAmsterdam Pharma Co N.V. (NAMSW)
NewAmsterdam Pharma Co N.V. (NAMSW)